abagovomab
abciximab
abelacimab
abituzumab
abrezekimab
abrilumab
actoxumab
adalimumab
adebrelimab
adecatumumab
aducanumab
afasevikumab
afelimomab
alacizumab
alemtuzumab
alirocumab
alsevalimab
altumomab
amatuximab
amivantamab
anatumomab
andecaliximab
anetumab
anifrolumab
anrukinzumab
apamistamab
apolizumab
aprutumab
arcitumomab
ascrinvacumab
aselizumab
astegolimab
atezolizumab
atidortoxumab
atinumab
atoltivimab
atorolimumab
avdoralimab
avelumab
avizakimab
axatilimab
azintuxizumab
balstilimab
bapineuzumab
basiliximab
batoclimab
bavituximab
bectumomab
befovacimab
begelomab
belantamab
belimumab
bemarituzumab
benralizumab
benufutamab
bepranemab
berlimatoxumab
bermekimab
bersanlimab
bertilimumab
besilesomab
bevacizumab
bexmarilimab
bezlotoxumab
biciromab
bimagrumab
bimekizumab
birtamimab
bivatuzumab
bleselumab
blinatumomab
blontuvetmab
blosozumab
bococizumab
brazikumab
brentuximab
briakinumab
brodalumab
brolucizumab
brontictuzumab
budigalimab
burosumab
cabiralizumab
camidanlumab
camrelizumab
canakinumab
cantuzumab
caplacizumab
capromab
carfavimab
carlumab
carotuximab
catumaxomab
cedelizumab
cemiplimab
cendakimab
cergutuzumab
certolizumab
cetrelimab
cetuximab   # ????? (82/44) / 19074 (120/82)
cevostamab
cibisatamab
cipanemab
citatuzumab
cixutumumab
clazakizumab
clenoliximab
clivatuzumab
cobolimab
codrituzumab
cofetuzumab
coltuximab
conatumumab
concizumab
cosfroviximab
cosibelimab
crenezumab
crizanlizumab
crotedumab
crovalimab
cudarolimab
cusatuzumab
dacetuzumab
daclizumab
dalotuzumab
dapirolizumab
daratumumab
datopotamab
dectrekumab
demcizumab
demprentamab
demupitamab
denintuzumab
denosumab
depatuxizumab
derlotuximab
detumomab
dezamizumab
dilpacimab
dinutuximab
diridavumab
disitamab
docaravimab
domagrozumab
donanemab
dorlimomab
dostarlimab
dovanvetmab
drozitumab
duligotuzumab
dupilumab
durvalumab
dusigitumab
duvortuxizumab
ecromeximab
eculizumab
edobacomab
edrecolomab
efalizumab
efungumab
eldelumab
elezanumab
elgemtumab
elipovimab
elotuzumab
elsilimomab
emactuzumab
emapalumab
emibetuzumab
emicizumab
enapotamab
enavatuzumab
encelimab
enfortumab
enlimomab
enoblituzumab
enokizumab
enoticumab
ensituximab
envafolimab
epcoritamab
epitumomab
epratuzumab
eptinezumab
erenumab
erlizumab
ertumaxomab
etaracizumab
etigilimab
etokimab
etrolizumab
evinacumab
evolocumab
exbivirumab
ezabenlimab
fanolesomab
faralimomab
faricimab
farletuzumab   # also 11877
fasinumab
felvizumab
felzartamab
fezakinumab
fianlimab
ficlatuzumab
figitumumab
firivumab
flanvotumab
fletikumab
flotetuzumab
fontolizumab
foralumab
foravirumab
fremanezumab
fresolimumab
frovocimab
frunevetmab
fulranumab
futuximab
galcanezumab
galiximab
gancotamab
ganitumab
gantenerumab
garadacimab
garetosmab
gatipotuzumab
gatralimab
gavilimomab
gedivumab
gemtuzumab
gevokizumab
giloralimab
gilvetmab
gimsilumab
girentuximab
glembatumumab
glenzocimab
glofitamab
golimumab
gontivimab
gosuranemab
gremubamab
guselkumab
ianalumab
ibalizumab
ibritumomab
icrucumab
idactamab
idarucizumab
iermilimab
ifabotuzumab
igomactamab
igovomab
iladatuzumab
imalumab
imaprelimab
imciromab
imgatuzumab
inclacumab
indatuximab
indusatumab
inebilizumab
infliximab
inolimomab
inotuzumab
intetumumab
ipilimumab
iratumumab
isatuximab
iscalimab
isecarosmab
istiratumab
itepekimab
itolizumab
ivuxolimab
ixekizumab
keliximab
labetuzumab
lacnotuzumab
lacutamab
ladiratuzumab
lampalizumab
lanadelumab
landogrozumab
laprituximab
larcaviximab
lebrikizumab
lecanemab
lemalesomab
lenvervimab
lenzilumab
lerdelimumab
leronlimab
lesofavumab
letolizumab
levilimab
lexatumumab
libivirumab
lifastuzumab
ligelizumab
lilotomab
lintuzumab
lirilumab
lodapolimab
lodelcizumab
lokivetmab
loncastuximab
lorvotuzumab
losatuxizumab
lucatumumab
lulizumab
lumiliximab
lumretuzumab
lupartumab
lutikizumab
maftivimab
magrolimab
manelimab
mapatumumab
margetuximab
marstacimab
maslimomab
matuzumab
mavrilimumab
mepolizumab
metelimumab
mezagitamab
milatuzumab
minretumomab
miptenalimab
mirikizumab
miromavimab
mirvetuximab
mirzotamab
mitazalimab
mitumomab
modotuximab
mogamulizumab
monalizumab
morolimumab
mosunetuzumab
motavizumab
moxetumomab
murlentamab
nacolomab
namilumab
naptumomab
naratuximab
narnatumab
narsoplimab
natalizumab
navicixizumab
navivumab
naxitamab
nebacumab
necitumumab
nemolizumab
nerelimomab
nesvacumab
netakimab
nimacimab
nimotuzumab
nirsevimab
nivolumab
nofetumomab
nomogakimab
nurulimab
obexilimab
obiltoxaximab
obinutuzumab
ocaratuzumab
ocrelizumab
odesivimab
odronextamab
odulimomab
ofatumumab
olaratumab
oleclumab
olendalizumab
olinvacimab
olokizumab
omalizumab
omburtamab
onartuzumab
ongericimab
ontamalimab
ontuxizumab
onvatilimab
opicinumab
oportuzumab
opucolimab
oregovomab
orilanolimab
orticumab
osocimab
otelixizumab
otilimab
otlertuzumab
oxelumab
ozanezumab
ozoralizumab
pacmilimab
pagibaximab
palivizumab
pamrevlumab
panitumumab
panobacumab
parsatuzumab
pascolizumab
pasotuxizumab
pateclizumab
patritumab
pembrolizumab
pepinemab
perakizumab
pertuzumab
petosemtamab
pexelizumab
pidilizumab
pinatuzumab
pintumomab
placulumab
plamotamab
plozalizumab
polatuzumab
ponezumab
porgaviximab
porlotamab
pozelimab
praluzatamab
prasinezumab
prezalumab
priliximab
pritoxaximab
pritumumab
prolgolimab
quavonlimab
quetmolimab
quilizumab
quobrivimab
racotumomab
radretumab
rafivirumab
ralpancizumab
ramucirumab
ranevetmab
ranibizumab
rastelimab
ravagalimab
ravulizumab
raxibacumab
refanezumab
regavirumab
relatlimab
relfovetmab
remtolumab
reslizumab
retifanlimab
revdofilimab
rilotumumab
rinucumab
ripertamab
risankizumab
rituximab
rivabazumab
robatumumab
roledumab
rolinsatamab
romilkimab
romosozumab
rontalizumab
rosmantuzumab
rosopatamab
rovalpituzumab
rovelizumab
rozanolixizumab
ruplizumab
ruvalvetmab
sabatolimab
sacituzumab
samalizumab
samrotamab
sarilumab
sasanlimab
satralizumab
satumomab
secukinumab
selicrelumab
semorinemab
serclutamab
seribantumab
serplulimab
setoxaximab
setrusumab
sevirumab
sibrotuzumab
sifalimumab
siltuximab
simtuzumab
sintilimab
siplizumab
sirtratumab
sirukumab
sofituzumab
solanezumab
solitomab
sonelokimab
sontuzumab
spartalizumab
spesolimab
stamulumab
sugemalimab
sulesomab
suptavumab
sutimlimab
suvizumab
suvratoxumab
tabalumab
#tacatuzumab
tadocizumab
tafasitamab
tafimkimab
tafolecimab
talacotuzumab
talizumab
talquetamab
tamrintamab
tamtuvetmab
tanezumab
taplitumomab
tarextumab
tasparkimab
tavolimab
tebotelimab
teclistamab
tefibazumab
telazorlimab
telimomab
telisotuzumab
temelimab
tenatumomab
teneliximab
teplizumab
tepoditamab
teprotumumab
tesidolumab
tesnatilimab
tezepelumab
tibulizumab
tidutamab
tigatuzumab
tilavonemab
tildrakizumab
tilogotamab
tilvestamab
timigutuzumab
timolumab
tinurilimab
tiragolumab
tislelizumab
tisotumab
tocilizumab
tomaralimab
tomuzotuximab
toralizumab
toripalimab
tosatoxumab
tositumomab
tovetumab
tralokinumab
trastuzumab
tregalizumab
tremelimumab
trevogrumab
tucotuzumab
tuvirumab
ublituximab
ulocuplumab
urabrelimab
urelumab
urtoxazumab
ustekinumab
utomilumab
vadastuximab
vandortuzumab
vantictumab
vanucizumab
vapaliximab
varisacumab
varlilumab
vatelizumab
vedolizumab
veltuzumab
vepalimomab
vesencumab
vibecotamab
vibostolimab
vilobelimab
visilizumab
vobarilizumab
vofatamab
volagidemab
volociximab
vonlerolizumab
vopratelimab
vorsetuzumab
votumumab
vulinacimab
vunakizumab
xentuzumab
zagotenemab
zalifrelimab
zalutumumab
zampilimab
zanidatamab
zanolimumab
zelminemab
zenocutuzumab
ziltivekimab
ziralimumab
zolbetuximab
zolimomab
zuberitamab

# Consultation 69 - for PL123
acapatamab #azurtamab
alnuctamab #alnectamab
apitegromab
bapotulimab
barecetamab #ebarcetamab
bentracimab
coprelotamab
dafsolimab
daxdilimab
depemokimab
divozilimab # replaces livozitamab
ebronucimab
enibarcimab
etevritamab
finotonlimab
gavivulimab
geptanolimab
grisnilimab
izuralimab #zurabulimab
letaplimab #letaraplimab
melrilimab
mipasetamab
nadunolimab # replaces nidanilimab
obrindatamab #abrindatamab
ociperlimab
omodenbamab
# pavunalimab # 11465 rejected
penpulimab
pimivalimab
recaticimab
sotigalimab
tarlatamab
tusamitamab
upifitamab
vixarelimab
vudalimab
# zelusalimab
zimbirelimab #zimberelimab

# Amgen bispecifics that they have rejected
eluvixtamab #
emerfetemab #
pancanalotamab
pavurutamab #avurutamab

# Consultation 70
mibavademab
lirentilimab
licaminlimab
lusvertilimab
amlitelimab
unasnemab
ordesekimab
domvanalimab
pucotenlimab
acasunlimab
nadecnemab
torudokimab
alomfilimab
sibeprenlimab
cadonilimab
ebdarokimab
latozinemab
nivatrotamab
plonmarlimab
uliledlimab
# tosramtamab - rejected by applicant
ponsegromab
anbenitamab
erfonrilimab
# neligikimab - rejected by applicant
# gipolenimab - rejected by applicant
zilovertamab
lonigutamab
tozorakimab
sudubrilimab
tirnovetmab
# avbotamab - rejected by applicant
lemzoparlimab
ansuvimab
botensilimab
favezelimab # was mavezelimab
zeluvalimab
serzebiclimab # replaces mirdevelimab
vixtimotamab  # replaces netimotamab & netimatamab
runimotamab   # munistamab
# 11340 to be decided - ismidolimab?
# New names for Covid
sotrovimab
tixagevimab
cilgavimab
zansecimab
casirivimab
zecricevimab  # Not published till clinical trials
imdevimab
aninavimab  # Not published till clinical trials
atibuclimab
etesevimab
bamlanivimab
regdanvimab
# Consult 71
ivicentamab   # 11702
voxalatamab   # 11734
tarcocimab    # 11770/11774
pulocimab     # 11807
gumokimab     # 11808
ligufalimab   # 11810
trinbelimab   # 11821
tuvonralimab  # 11841
tagitanlimab  # 11843
burfiralimab  # 11669 (not really a li)
fidasimtamab  # 11670
socazolimab   # 11672
# crefmirtamab  # 11678 (rejected - and made a -li-)
ubamatamab    # 11679
suciraslimab  # 11682
# mafancavimab  # 11685 (rejected - mafan in Chinese means trouble)
tanigiblimab  # 11690
pivekimab     # 11693/11695
ulenistamab   # 11699
anselamimab   # 11703
rulonilimab   # 11710
anumigilimab  # 11718
melradableukin # 11723 - non-functional complete antibody
tecaginlimab  # 11729
simridarlimab # 11730
livmoniplimab # 11741
mazorelvimab  # 11745
zamerovimab   # 11747
sirexatamab   # 11751
lorigerlimab  # 11771
exidavnemab   # 11775
ecleralimab   # 11791
gresonitamab  # 11798
rocatinlimab  # 11800
ivonescimab   # 11809
manfidokimab  # 11811
vepsitamab    # 11822
ormutivimab   # 11825
brubometamab  # 11836/11837 Capped cysteines - deferred naked ab
elranatamab   # 11838
gumoselimab   # 11840
barzelvolimab # 11842
bafisontamab  # 11851
clesrovimab   # 11857 Consult72 - pending from usan
teropavimab   # 11878
# inetravimab   # 11879 rejected (etravine too close)
eblasakimab   # 11881
nofasinlimab  # 11892
pibocalimab   # 11192 was icatolimab
ginisortamab  # 11604 was tosramtamab
xeligikimab   # 11625 was neligikimab
galegenimab   # 11632 was gipolenimab  -eni- enzyme
sotevtamab    # 11666 was avbotamab
# Consult 72
pelgifatamab  # 11920
betifisolimab # 11926
osemitamab    # 11927
ifinatamab    # 11954/55
cirevetmab    # 11970
posdinemab    # 11987
fazpilodemab  # 12017
luveltamab    # 12040/41 (has non-natural AAs)
visugromab    # 12044
imvotamab     # 12054
trosunilimab  # 12071
gorpefecimab  # 12086
vicasinab     # 11940 (second table)
linvoseltamab # 12104
reozalimab    # 11904
izenivetmab   # 11906
anivovetmab   # 11907
rosnilimab    # 11909
lesabelimab   # 11914
litifilimab   # 11943
mupadolimab   # 11944
mecbotamab    # 11946 / 11951
ozuriftamab   # 11947 / 11952
boserolimab   # 11948
almepolimab   # 11957 
peresolimab   # 11958
beludavimab   # 11961
frexalimab    # 11963
upanovimab    # 11966 (mine)
acrixolimab   # 11969
cifurtilimab  # 11973
gefurulimab   # 11982
amubarvimab   # 11988 with 11992 for SARS
romlusevimab  # 11992 SARS
lomtegovimab  # 12001
golocdacimab  # 12003 sars
enuzovimab    # 12009 sars
aliprasvimab   # 12011 (mine)
izalontamab   # 12022
emfizatamab   # 12023
adintrevimab  # 12026
emirodatamab  # 12028
rimteravimab  # 12047 SARS
fiztasovimab  # 12050
vobramitamab  # 12056 / 12057
camoteskimab  # 12062 (camote is sweet potato in Spanish)
ivatrevimab   # 12070 sars
ispectamab    # 12079
tarpaxutamab  # 12082
inezetamab    # 12088
omdatovimab   # 12094 sars
quisovalimab  # 12100
dresbuxelimab # 12115
trontinemab   # 12120
briquilimab   # 12124
# 11669 rejected with no reason but retained
crefmirlimab  # 11678 replacement name
semzuvolimab  # 11685 replacement name
zinlirvimab   # 11879 replacement name
bavunalimab   # 11465 replacement name
